规模化、供应保障与给药系统的一体化策略
随着 GLP-1 疗法持续重塑制药行业格局，制药企业面临着越来越大的压力，既要缩短开发周期，又要确保生产规模扩展能力和供应链准备就绪。
在本次网络研讨会中，斯蒂瓦那托集团(Stevanato Group) 将探讨 GLP-1 项目开发过程中在选择药物包材系统、给药装置以及生产制造策略时所涉及的关键决策。
了解 斯蒂瓦那托集团(Stevanato Group) 的一体化解决方案如何帮助降低开发风险、增强供应链韧性，并支持产品从早期开发到大规模商业化生产的成功推进。
演讲嘉宾
Stevanato Group
Stevanato Group is a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle at each of the development, clinical, and commercial stages.